Worth reading
40Recurring
Scored from 5 of 6 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
-17.9
% (year-on-year change in operating profit)Wording
Conditional
How definitive the wording is.Results for this period
First quarter2025年4月1日〜2025年6月30日ConsolidatedJapanese GAAPNet Sales13,681¥ millionYear on year +0.5%Progress 23.2%
Operating profit957¥ millionYear on year -17.9%Progress 29.0%
Ordinary income1,091¥ millionYear on year -23.9%Progress 30.3%
Net income attributable to owners of the parent748¥ millionYear on year -22.7%Progress 31.2%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share32円82銭
Financial position at period-end
Total assets88,204¥ million
of which net assets 59,475 ¥ millionEquity ratio 66.8%vs. prior year-end +0.2pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Segment revenueFunctional Materials Business ¥6,889 million (YoY -5.9%), Electronic materials and chemicals business ¥6,519 million (YoY +8.4%), Other (outside reportable segments) ¥272 million (YoY -0.2%)
Segment profitFunctional Materials Business ¥289 million, Electronic materials and chemicals business ¥605 million, Other (outside reportable segments) ¥59 million
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥59,000 million (YoY +5.9%)
Operating profit¥3,300 million (YoY -6.4%)
Ordinary income¥3,600 million (YoY -3.9%)
Net income¥2,400 million (YoY -0.9%)
Annual Dividend Forecast38 円（1株当たり、前期実績から今期予想） → 40 円（1株当たり、前期実績から今期予想）（+5.3%）
Factors Behind Changes in Business Performance
導電性高分子薬剤の販売が車載用コンデンサ向けを中心に伸長し、界面活性剤の販売が好調に推移したものの、機能性材料事業の製品の販売が低調であったこと等
Disclosure regarding the going concern assumption
No applicable matters
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationMaterial changes No / New Not disclosed / Excluded Not disclosed
Impairment lossNo applicable matters
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of investment securities ¥2 million / Extraordinary loss Loss on Disposal of Fixed Assets ¥27 million
Depreciation and amortization¥737 million
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingNo (no eligible attendees)
Issued Shares at Period-End23,914,414
Treasury Shares at Period-End1,096,270
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2025年4月1日〜2025年6月30日 |
| Net Sales | ¥13,681 million (YoY +0.5%) |
| Operating profit | ¥957 million (YoY -17.9%) |
| Ordinary income | ¥1,091 million (YoY -23.9%) |
| Profit attributable to owners of the parent | ¥748 million (YoY -22.7%) |
| Net income per share | 32円82銭 |
| Equity ratio | End of the current fiscal period 66.8 / End of previous period 66.6 |
| Total assets | ¥88,204 million |
| Net assets | ¥59,475 million |
| Full-year earnings forecast | Net Sales ¥59,000 million (YoY +5.9%) / Operating profit ¥3,300 million (YoY -6.4%) / Ordinary income ¥3,600 million (YoY -3.9%) / Net income ¥2,400 million (YoY -0.9%) |
| Annual Dividend Forecast | 38 円（1株当たり、前期実績から今期予想） → 40 円（1株当たり、前期実績から今期予想）（+5.3%） |
| Segment revenue | Functional Materials Business ¥6,889 million (YoY -5.9%), Electronic materials and chemicals business ¥6,519 million (YoY +8.4%), Other (outside reportable segments) ¥272 million (YoY -0.2%) |
| Segment profit | Functional Materials Business ¥289 million, Electronic materials and chemicals business ¥605 million, Other (outside reportable segments) ¥59 million |
| Depreciation and amortization | ¥737 million |
| Impairment loss | No applicable matters |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of investment securities ¥2 million / Extraordinary loss Loss on Disposal of Fixed Assets ¥27 million |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | Material changes No / New Not disclosed / Excluded Not disclosed |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No (no eligible attendees) |
| Issued Shares at Period-End | 23,914,414 |
| Treasury Shares at Period-End | 1,096,270 |
| Factors Behind Changes in Business Performance | 導電性高分子薬剤の販売が車載用コンデンサ向けを中心に伸長し、界面活性剤の販売が好調に推移したものの、機能性材料事業の製品の販売が低調であったこと等 |
Items this document does not state (11)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogMaterial subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.導電性高分子薬剤の販売が車載用コンデンサ向けを中心に伸長し、界面活性剤の販売も好調に推移した一方、機能性材料事業の製品販売が低調であったことなどによるものです。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.